Activation of circulating platelets in patients with peripheral arterial disease during digital subtraction angiography and percutaneous transluminal angioplasty

Thrombosis Research

Volumn 109, Issue 1, 2003, Pages 13-22

  Buchholz, Alexander Matthias ^a   Bruch, Leonhard ^b   Schulte, Karl Ludwig ^b  

^a Paulinenkrankenhaus ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Digital subtraction angiography; Flow cytometry; P selectin; Percutaneous transluminal angioplasty; Peripheral arterial disease; Platelet activation

Indexed keywords

ACTIVATION DEPENDENT PLATELET ANTIGEN; ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTERY DISEASE; ARTICLE; CELL ASSAY; CELL MIGRATION; CELL SURVIVAL; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE CLASSIFICATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEG; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0037243760     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00113-0     Document Type: Article

References (38)

1. Itoh T., Nakai K., Ono M., Hiramori K. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin? Coron. Artery Dis. 6(8):1995;645-650.
2. Gawaz M., Neumann F.J., Ott I., Schiessler A., Schomig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 93(2):1996;229-237.
3. Tschoepe D., Driesch E., Schwippert B., Nieuwenhuis H.K., Gries F.A. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes. 44(8):1995;890-894.
4. Tschoepe D., Schultheiss H.P., Kolarov P., Schwippert B., Dannehl K., Nieuwenhuis H.K.et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation. 88(1):1993;37-42.
5. Grau A.J., Ruf A., Vogt A., Lichy C., Buggle F., Patscheke H.et al. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb. Haemost. 80(2):1998;298-301.
6. Holmsen H. Platelet secretion and energy metabolism. Colman R.W., Hirsh J., Marder V.J., Salzman E.W. Hemostasis and thrombosis. 1994;524-545 J.B. Lippincott, Philadelphia.
7. Rohrer M.J., Kestin A.S., Ellis P.A., Barnard M.R., Rodino L., Breckwoldt W.L.et al. High-dose heparin suppresses platelet alpha granule secretion. J. Vasc. Surg. 15(6):1992;1000-1008. (discussion 1008-1009).
8. Tschoepe D., Roesen P., Schwippert B., Gries F.A. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin. Thromb. Hemost. 19(2):1993;122-128.
9. Spangenberg P., Redlich H., Bergmann I., Losche W., Gotzrath M., Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb. Haemost. 70(3):1993;514-521.
10. Ruf A., Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin. Thromb. Hemost. 21(2):1995;146-151.
11. Morse D.S., Adams D., Magnani B. Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. Ann. Thorac. Surg. 65(3):1998;691-695.
12. Ishiwata S., Tukada T., Nakanishi S., Nishiyama S., Seki A. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am. Heart J. 133(4):1997;387-392.
13. Shlansky-Goldberg R. Platelet aggregation inhibitors for use in peripheral vascular interventions: what can we learn from the experience in the coronary arteries? J. Vasc. Interv. Radiol. 13(3):2002;229-246.
14. Matsagas M.I., Geroulakos G., Mikhailidis D.P. The role of platelets in peripheral arterial disease: therapeutic implications. Ann. Vasc. Surg. 16(2):2002;246-258.
15. Agnelli G. Rationale for the use of platelet aggregation inhibitors in PAD patients. Vasc. Med. 6(Suppl. 3):2001;13-15.
16. Hofmann L.V., Razavi M., Arepally A., Reginelli J.P., Resar J., Geschwind J.F.et al. GPIIb-IIIa receptor inhibitors: what the interventional radiologist needs to know. Cardiovasc. Interv. Radiol. 24(6):2001;361-370.
17. Miller D.D., Rivera F.J., Garcia O.J., Palmaz J.C., Berger H.J., Weisman H.F. Imaging of vascular injury with 99mTc-labeled monoclonal antiplatelet antibody S12. Preliminary experience in human percutaneous transluminal angioplasty. Circulation. 85(4):1992;1354-1363.
18. Brothers T.E., Robison J.G., Elliott B.M., Boggs J.M. Preoperative thromboxane A2/prostaglandin H2 receptor activity predicts early graft thrombosis. J. Vasc. Surg. 27(2):1998;317-328.
19. Blann A.D., Adams R., Ashleigh R., Naser S., Kirkpatrick U., McCollum C.N. Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease. Br. J. Radiol. 74(885):2001;811-817.
20. Andrioli G., Ortolani R., Fontana L., Gaino S., Bellavite P., Lechi C.et al. Study of platelet adhesion in patients with uncomplicated hypertension. J. Hypertens. 14(10):1996;1215-1221.
21. Drexler H., Zeiher A.M., Wollschlager H., Meinertz T., Just H., Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation. 80(3):1989;466-474.
22. De Servi S., Mazzone A., Ricevuti G., Fioravanti A., Bramucci E., Angoli L.et al. Granulocyte activation after coronary angioplasty in humans. Circulation. 82(1):1990;140-146.
23. Tillmanns H., Neumann F.J., Tiefenbacher C., Dorigo O., Parekh N., Waas W.et al. Activation of neutrophils in the microvasculature of the ischaemic and reperfused myocardium. Eur. Heart J. 14(Suppl. I):1993;82-86.
24. Gawaz M., Ruf A., Neumann F.J., Pogatsa-Murray G., Dickfeld T., Zohlnhofer D.et al. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Thromb. Haemost. 80(6):1998;994-1001.
25. Ruf A., Pick M., Deutsch V., Patscheke H., Goldfarb A., Rachmilewitz E.A.et al. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br. J. Haematol. 98(1):1997;51-56.
26. Ault K.A., Rinder H.M., Mitchell J.G., Rinder C.S., Lambrew C.T., Hillman R.S. Correlated measurement of platelet release and aggregation in whole blood. Cytometry. 10(4):1989;448-455.
27. Schneider D.J., Tracy P.B., Mann K.G., Sobel B.E. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation. 96(9):1997;2877-2883.
28. Hay K.L., Bull B.S. An analysis of platelet activation and aggregation produced by three classes of contrast media. J. Vasc. Interv. Radiol. 6(2):1995;211-217.
29. Michelson A.D., Ellis P.A., Barnard M.R., Matic G.B., Viles A.F., Kestin A.S. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood. 77(4):1991;770-779.
30. Schmitz G., Rothe G., Ruf A., Barlage S., Tschope D., Clemetson K.J.et al. European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb. Haemost. 79(5):1998;885-896.
31. Minar E., Ehringer H., Ahmadi R., Dudczak R., Porenta G. Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA-(1.0 g/day)-therapy. Thromb. Haemost. 58(2):1987;718-723.
32. Chronos N.A., Goodall A.H., Wilson D.J., Sigwart U., Buller N.P. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation. 88(5 Pt. 1):1993;2035-2044.
33. Scharf R.E., Tomer A., Marzec U.M., Teirstein P.S., Ruggeri Z.M., Harker L.A. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler. Thromb. 12(12):1992;1475-1487.
34. Zeiger F., Stephan S., Hoheisel G., Pfeiffer D., Ruehlmann C., Koksch M. P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul. Fibrinolysis. 11(8):2000;723-728.
35. Koksch M., Zeiger F., Wittig K., Siegemund A., Reininger C.B., Pfeiffer D.et al. Coagulation, fibrinolysis and P-selectin expression in peripheral vascular disease. Eur. J. Vasc. Endovasc. Surg. 21(2):2001;147-154.
36. Reininger C.B., Boeger C.A., Steckmeier B., Spannagl M., Schweiberer L. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results. Int. Angiol. 18(2):1999;163-170.
37. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger A.L. III, Furman M.I. Evaluation of platelet function by flow cytometry. Methods. 21(3):2000;259-270.
38. O'Donnell C.J., Larson M.G., Feng D., Sutherland P.A., Lindpaintner K., Myers R.H.et al. Framingham heart study. Genetic and environmental contributions to platelet aggregation: the Framingham Heart Study. Circulation. 103(25):2001;3051-3056.